European drug regulators have found no significant evidence linking GLP-1 drugs like Ozempic and Wegovy to thoughts of suicide or self-harm. The Food and Drug Administration reached the same conclusion in January.
In the latest round of studies, doctors suggested the blockbuster medication - behind a now $80billion market - could lower the risk of multiple sclerosis (MS) by up to 80 percent and even ease sleep apnea in patients.
Zepbound in shortage beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.
Zepbound Patients in Panic Mode as Pharmacies Can t Get Enough bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.